Labcorp Expands Epic Pact to Make Full Test Menu Available on Aura

Why It Matters

Integrating its full catalog into Aura reduces integration barriers, boosting Labcorp’s competitive position and accelerating digital health adoption across health systems.

Key Takeaways

• Labcorp adds full test menu to Epic’s Aura platform.
• Over 400 genetic tests now orderable within Epic EHR.
• Integration cuts IT complexity and manual fax processes.
• Competes directly with Quest Diagnostics on the same platform.

Pulse Analysis

The healthcare industry has long wrestled with fragmented lab ordering, relying on faxed requests and disparate result PDFs. Epic’s Aura platform was created to centralize this workflow, allowing physicians to order tests and view results within the familiar Epic EHR interface. By aggregating multiple diagnostic partners—ranging from genetic specialists to cardiac monitoring firms—Aura streamlines data exchange, reduces manual errors, and shortens the time from order to diagnosis, a critical factor in patient care pathways.

Labcorp’s decision to extend Aura to its full test menu marks a strategic escalation in the race for digital dominance. Previously, only a subset of Labcorp’s inherited Invitae genetic panels were available through the platform; now more than 400 hereditary and clinical tests can be ordered seamlessly. This expansion not only simplifies onboarding for health systems—eliminating the need for custom integrations—but also positions Labcorp alongside Quest Diagnostics, which has already leveraged Aura for oncology, prenatal, and Alzheimer’s assays. The move is expected to lower Labcorp’s IT overhead, reduce reliance on workarounds, and improve turnaround times, thereby enhancing its value proposition to providers.

Beyond Labcorp, the broader market sees Aura’s growth as a catalyst for accelerated EHR‑lab convergence. As more diagnostic and med‑tech firms join the network, health systems can achieve a unified ordering experience, driving operational efficiencies and supporting value‑based care models. The platform’s expansion also signals a shift toward interoperable, cloud‑based solutions that can adapt to emerging tests and technologies. For stakeholders, this translates into faster adoption of innovative diagnostics, reduced administrative burdens, and ultimately, better patient outcomes.